532296:BOM
Glenmark Pharmaceuticals Ltd
₹2,235.85
arrow_downward
-0.64%(-14.45) 1D
Oct 16, 2:41:21 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532296...
Open
₹2,249.80
High
₹2,264.00
Low
₹2,232.50
Mkt. cap
630.97B
Avg. vol.
17.97K
Volume
8.46K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.11
52-wk high
₹2,536.85
52-wk low
₹1,794.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,249.80
High
₹2,264.00
Low
₹2,232.50
Mkt. cap
630.97B
Avg. vol.
17.97K
Volume
8.46K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.11
52-wk high
₹2,536.85
52-wk low
₹1,794.00
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
FXLeaders
·
8 minutes ago
Dow Futures Hold Firm at 52.5K as Value Rotation Offsets Tech Pressure
www.inc.com
·
1 minute ago
Stock Pickers’ Long Odds Have a History
Bloomberg
·
35 minutes ago
European Shares Outperform S&P 500 Amid Defensive Tilt From AI
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd